BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 20658594)

  • 1. Iatrogenic immunodeficiency-associated lymphoproliferative disease of the Hodgkin lymphoma-like variant in a patient treated with mycophenolate mofetil for autoimmune hepatitis.
    Adams B; Lazarchick J; Medina AM; Willner IR; Neville B; Murphy E; Stuart R; Costa LJ
    Am J Hematol; 2010 Aug; 85(8):627-9. PubMed ID: 20658594
    [No Abstract]   [Full Text] [Related]  

  • 2. Post-transplant lymphoproliferative disorder presenting as multiple myeloma.
    Ninan MJ; Datta YH
    Am J Hematol; 2010 Aug; 85(8):635-7. PubMed ID: 20578201
    [No Abstract]   [Full Text] [Related]  

  • 3. Diffuse large B-cell lymphoma of the central nervous system in mycophenolate mofetil-treated patients with systemic lupus erythematosus.
    Tsang HH; Trendell-Smith NJ; Wu AK; Mok MY
    Lupus; 2010 Mar; 19(3):330-3. PubMed ID: 19897521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of cellular origin and EBV status in a PTLD after double cord blood transplantation.
    Reddiconto G; Chiusolo P; Fiorini A; Farina G; Laurenti L; Martini M; Marchetti S; Fadda G; Leone G; Sica S
    Leukemia; 2007 Dec; 21(12):2552-4. PubMed ID: 17597809
    [No Abstract]   [Full Text] [Related]  

  • 5. Epstein-Barr virus-associated lymphoproliferation awareness in hemophagocytic syndrome complicating thiopurine treatment for Crohn's disease.
    Serrate C; Silva-Moreno M; Dartigues P; Poujol-Robert A; Sokol H; Gorin NC; Coppo P
    Inflamm Bowel Dis; 2009 Oct; 15(10):1449-51. PubMed ID: 19177429
    [No Abstract]   [Full Text] [Related]  

  • 6. Multifocal polyclonal Epstein-Barr virus-associated B-cell lymphoproliferative disorder secondary to azathioprine therapy successfully treated with rituximab.
    Courby S; Fabre B; Salameire D; Gaulard P; Hincky-Vitrat V; Gressin R; Bonaz B; Epaulard O
    Leuk Lymphoma; 2010 Jan; 51(1):174-7. PubMed ID: 20001240
    [No Abstract]   [Full Text] [Related]  

  • 7. Epstein-Barr virus-driven lymphoproliferative disorder post-CAMPATH-1H (alemtuzumab) in refractory polymyositis.
    Cooles FA; Jackson GH; Menon G; Isaacs JD
    Rheumatology (Oxford); 2011 Apr; 50(4):810-2. PubMed ID: 21208978
    [No Abstract]   [Full Text] [Related]  

  • 8. EBV-associated lymphoproliferative disorder of CNS associated with the use of mycophenolate mofetil.
    O'Neill BP; Vernino S; Dogan A; Giannini C
    Neuro Oncol; 2007 Jul; 9(3):364-9. PubMed ID: 17522336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine.
    Richardson PD; James PD; Ryder SD
    J Hepatol; 2000 Sep; 33(3):371-5. PubMed ID: 11019991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus (EBV)--associated posttransplant lymphoproliferative disorder appearing as mandibular gingival ulcers.
    Amorim Pellicioli AC; Luciano AA; Rangel AL; de Oliveira GR; Santos Silva AR; de Almeida OP; Vargas PA
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Apr; 121(4):e80-6. PubMed ID: 26321430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effectiveness and safety of rituximab in pemphigus vulgaris].
    Alonso Sánchez A; García Rodríguez S; López Avila A; Rabell Iñigo S
    Farm Hosp; 2010; 34(2):98-9. PubMed ID: 20304370
    [No Abstract]   [Full Text] [Related]  

  • 12. Association of Epstein-Barr virus with regression after withdrawal of immunosuppressive drugs and subsequent progression of iatrogenic immunodeficiency-associated lymphoproliferative disorders in patients with autoimmune diseases.
    Fujimoto K; Hatanaka KC; Hatanaka Y; Kasahara I; Yamamoto S; Tsuji T; Nakata M; Takakuwa Y; Haseyama Y; Oyamada Y; Yonezumi M; Suzuki H; Sakai H; Noguchi H; Mori A; Nishihara H; Teshima T; Matsuno Y
    Hematol Oncol; 2020 Dec; 38(5):799-807. PubMed ID: 32798315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus-positive mucocutaneous ulcers as a manifestation of methotrexate-associated B-cell lymphoproliferative disorders.
    Hashizume H; Uchiyama I; Kawamura T; Suda T; Takigawa M; Tokura Y
    Acta Derm Venereol; 2012 May; 92(3):276-7. PubMed ID: 22293895
    [No Abstract]   [Full Text] [Related]  

  • 14. Azathioprine-induced reversible EBV-associated Hodgkin-like lymphoma after immunosuppressive therapy for autoimmune hepatitis
.
    Munz M; Pretscher D; Wilhelm M; Holzgrabe U; Sörgel F; Birkmann J
    Int J Clin Pharmacol Ther; 2018 Mar; 56)(3):142-147. PubMed ID: 29292695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent classical Hodgkin lymphoma and plasmablastic lymphoma in a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma treated with fludarabine: a dimorphic presentation of iatrogenic immunodeficiency-associated lymphoproliferative disorder with evidence suggestive of multiclonal transformability of B cells by Epstein-Barr virus.
    Foo WC; Huang Q; Sebastian S; Hutchinson CB; Burchette J; Wang E
    Hum Pathol; 2010 Dec; 41(12):1802-8. PubMed ID: 20869749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two rare cases of Epstein-Barr virus-associated lymphoproliferative disorders in inflammatory bowel disease patients on thiopurines and other immunosuppressive medications.
    Subramaniam K; Cherian M; Jain S; Latimer M; Corbett M; D'Rozario J; Pavli P
    Intern Med J; 2013 Dec; 43(12):1339-42. PubMed ID: 24330365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resolution of methotrexate-induced Epstein-Barr virus-associated mucocutaneous ulcer.
    Sadasivam N; Johnson RJ; Owen RG
    Br J Haematol; 2014 Jun; 165(5):584. PubMed ID: 24456137
    [No Abstract]   [Full Text] [Related]  

  • 18. Mycophenolate mofetil as a rescue therapy for autoimmune hepatitis patients who are not responsive to standard therapy.
    Fallatah HI; Akbar HO
    Expert Rev Gastroenterol Hepatol; 2011 Aug; 5(4):517-22. PubMed ID: 21780898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histological changes after the use of mycophenolate mofetil in autoimmune hepatitis.
    Brunt EM; Di Bisceglie AM
    Hum Pathol; 2004 Apr; 35(4):509-12. PubMed ID: 15116334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid remission of steroid and mycophenolate mofetil (mmf)-resistant minimal change nephrotic syndrome after rituximab therapy.
    Yang T; Nast CC; Vo A; Jordan SC
    Nephrol Dial Transplant; 2008 Jan; 23(1):377-80. PubMed ID: 17981884
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.